New-onset Systemic Lupus Erythematosus Manifestation Following COVID-19: A Case Report and Literature Review-Reference-Cited by-同舟云学术

New-onset Systemic Lupus Erythematosus Manifestation Following COVID-19: A Case Report and Literature Review

Published:2024-05-15 Issue:10 Volume:63 Page:1491-1498
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Sumichika Yuya¹,Temmoku Jumpei¹,Saito Kenji¹,Yoshida Shuhei¹,Matsumoto Haruki¹,Watanabe Guy²,Utsumi Akihito³,Fujita Yuya¹,Matsuoka Naoki¹,Asano Tomoyuki¹,Sato Shuzo¹,Migita Kiyoshi¹

Affiliation:

1. Department of Rheumatology, Fukushima Medical University School of Medicine, Japan

2. Department of Nephrology and Hypertension, Fukushima Medical University School of Medicine, Japan

3. Department of Diagnostic Pathology, Fukushima Medical University, School of Medicine, Japan

Publisher

Japanese Society of Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/63/10/63_3211-23/_pdf

Reference37 articles.

1. 1. Sharma A, Tiwari S, Deb MK, Marty JL. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies. Int J Antimicrob Agents 56: 106054, 2020.

2. 2. Matthay MA, Zemans RL, Zimmerman GA, et al. Acute respiratory distress syndrome. Nat Rev Dis Primers 5: 18, 2019.

3. 3. Desai AD, Lavelle M, Boursiquot BC, Wan EY. Long-term complications of COVID-19. Am J Physiol Cell Physiol 322: C1-C11, 2022.

4. 4. Peng K, Li X, Yang D, et al. Risk of autoimmune diseases following COVID-19 and the potential protective effect from vaccination: a population-based cohort study. EClinicalMedicine 63: 102154, 2023.

5. 5. Zhou SY, Zhang C, Shu WJ, et al. Emerging roles of coronavirus in autoimmune diseases. Arch Med Res 52: 665-672, 2021.